Trellus Health PLC (GB:TRLS) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Trellus Health PLC has made significant strides in its chronic condition management programs, particularly for IBD, with the signing of major B2B2C agreements and a promising partnership with a large US health plan. The company concluded its pilot programs successfully and entered into licensing agreements with pharmaceutical companies, illustrating the value of its proprietary methodology. Despite a net cash decrease, Trellus Health’s careful cash management has extended its operational runway into mid-2025, with a focus on continued commercial growth and improved health outcomes.
For further insights into GB:TRLS stock, check out TipRanks’ Stock Analysis page.
